Hypothermia Clinical Trial
Official title:
Pharmacokinetics of Ampicillin in Neonates With Moderate to Severe Hypoxic-Ischemic Encephalopathy Undergoing Controlled Hypothermia
Controlled Hypothermia has become the standard of care for neonates with moderate to severe HIE. Ampicillin and aminoglycosides are drugs that are universally used for the treatment of suspected neonatal sepsis, which may or may not be responsible for the etiology of HIE. Currently, medication dosage regimens are not altered in the setting of CH. A better understanding of the effects of our interventions on this unique population may help us tailor our therapy to the specific circumstances of the patient
Hypoxic-ischemic encephalopathy (HIE) affects approximately 1 to 2 per 1000 live births and
remains a cause of significant morbidity and mortality in the neonatal period. In response
to an anoxic insult, perfusion to vital organs is preserved; however, when this injury is
profound concomitant injury to nonvital organs is observed. Controlled hypothermia (CH) has
been accepted as a neuroprotective therapeutic modality for neonates with moderate to severe
HIE because of its role in attenuating secondary brain injury. Neonates exhibit varying
degrees of multiorgan dysfunction after a hypoxic-ischemic insult, although the added
beneficial and potential adverse effects that CH has in these babies have not been
completely delineated or understood.
CH has been shown to alter normal physiologic functioning of several organ systems. Specific
physiologic changes as a consequence of CH have been demonstrated in both animal and human
models. The observed reduction in cardiac output and reflexive increase in systemic vascular
resistance in response to CH alter renal perfusion and subsequently reduce glomerular
filtration . Drugs that are renally cleared may develop a prolonged half-life in this
setting. Finally, drug metabolism may further be affected by altered hepatic blood flow and
temperature-dependent effects on hepatic enzyme activity . Collectively, the potential
effects of CH on drug metabolism and clearance are significant warranting further
investigation. The investigator aims to evaluate the combined effects of hypoxia and
hypothermia on ampicillin clearance and excretion
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05669313 -
The Effects of Hypothermia and Acidosis on Coagulation During Treatment With Rivaroxaban Measured With ROTEM
|
||
Not yet recruiting |
NCT05306392 -
Effects of Induced Moderate Hypothermia on ARDS Patients Under Venovenous ExtraCorporeal Membrane Oxygenation
|
N/A | |
Completed |
NCT02685176 -
Head and Torso Rewarming Using a Human Model for Severe Hypothermia
|
N/A | |
Withdrawn |
NCT02812069 -
WarmSmart Warming Protocol
|
N/A | |
Completed |
NCT02586974 -
Effects of Warmed, Humidified CO2 Insufflation on Body Core Temperature and Cytokine Response
|
N/A | |
Completed |
NCT02742818 -
Forced-air Warming in Endovascular Surgery: Testing Effectiveness of Two Different Blanket Models
|
N/A | |
Completed |
NCT02121574 -
Accuracy of Zero-flux and Ingestible Thermometers
|
N/A | |
Not yet recruiting |
NCT02211703 -
National Epidemiologic Survey on the Incidence of Perioperative Hypothermia
|
N/A | |
Completed |
NCT02177903 -
Study to Determine the Effects of Pre-warming on OR Patient Temperatures and Surgical Outcomes
|
N/A | |
Recruiting |
NCT01866384 -
Targeted Temperature Management After Intracerebral Hemorrhage
|
Phase 2 | |
Active, not recruiting |
NCT01529658 -
Renal Hypothermia During Partial Nephrectomy
|
N/A | |
Completed |
NCT01793337 -
Core Body Temperature Measurement During Hot and Cold Environmental Exposure
|
N/A | |
Completed |
NCT01722955 -
Pre-warmed Intravenous Fluids and Monitored Anesthesia Care
|
N/A | |
Completed |
NCT01559675 -
Trial Comparing Low Dose and High Dose Steroids in Patients Undergoing Colorectal Surgery
|
N/A | |
Terminated |
NCT01018576 -
Delayed Cord Clamping in Premature Infants
|
N/A | |
Completed |
NCT00904228 -
Plastic Hat Trial to Prevent Hypothermia in Preterm Newborns in the Delivery Room
|
N/A | |
Terminated |
NCT00822796 -
Thermogard™ Efficacy Trial
|
N/A | |
Completed |
NCT00334360 -
Dexmed/Buspirone Synergism on Shivering
|
Phase 4 | |
Not yet recruiting |
NCT06283771 -
The Effect of Heated Socks Developed With Wearable Technology on Hypothermia, Thermal Comfort Perception and Shivering
|
N/A | |
Completed |
NCT04399902 -
Study to Actively Warm Trauma Patients
|
N/A |